This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Omnicell Recognized With Worldwide Windows Embedded Partner Excellence Award





MOUNTAIN VIEW, Calif., Feb. 13, 2013 /PRNewswire/ --  Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, was recently honored by Microsoft as a worldwide Windows Embedded Partner Excellence Award recipient for intelligent systems healthcare solutions at the 2012 Intelligent Systems Leadership Summit held on the Microsoft campus in Redmond, Wash.

(Logo:  http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

The Windows Embedded Partner Excellence Awards recognize members of the Windows Embedded Partner Program that excel at driving the Windows Embedded business and the development of intelligent systems worldwide. Intelligent systems represent the evolution of the embedded device market that enables data to flow across an enterprise infrastructure, spanning the devices where valuable data is gathered from employees and customers, to the back-end systems where that data can be translated into insights and action.

"Omnicell is honored to be recognized by Windows Embedded as a key innovator for the emerging intelligent health systems market," said Marga Ortigas-Wedekind, executive vice president, global marketing and product development at Omnicell. "This award demonstrates our commitment to working with Microsoft to provide cutting edge solutions. Omnicell's G4 medication management system runs on the Windows Embedded Standard 7 operating system, which has empowered healthcare providers with improved security, a more streamlined Windows update process and long end-of-life and technical support."

"Healthcare is a major industry that is benefitting from intelligent systems created by partners like Omnicell," said Valerie Olague, Windows Embedded business group lead, Americas at Microsoft. "We are excited to recognize Omnicell for their innovation in improving the healthcare environment and patient care alike."

The Windows Embedded Partner Program is a strategic worldwide program that provides partners with increased business opportunities, market awareness and technology advice. For more information about the Windows Embedded Partner Program, visit: http://www.microsoft.com/windowsembedded/en-us/partners/

About Omnicell

For over 20 years the mission of Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.Since 1992, more than 2,600 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions that can reduce costly hospital readmissions and enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL - G

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,967.64 +254.98 1.44%
S&P 500 2,070.52 +9.50 0.46%
NASDAQ 4,922.4170 +31.1980 0.64%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs